2.2999
-0.0201 (-0.87%)
-0.0201 (-0.87%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.51
High
3.57
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sesen Bio Inc | SESN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0201 | -0.87% | 2.2999 | 00:00:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.30 | 2.20 | 2.32 | 2.30 | 2.32 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.00 | 3.60 | 1.60 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,479 | 3,136,540 | $ 2.26 | $ 7,095,188 | 4,322,190 | 0.51 - 3.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:15 | formt | 400 | $ 2.2999 | USD |
Sesen Bio Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 297.47M | 129.34M | 129.27M | $ - | $ - | -1.21 | -3.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Sesen Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SESN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.63 | 2.63 | 2.19 | 2.38 | 5,997,108 | -0.3301 | -12.55% |
| 1 Month | 3.08 | 3.57 | 2.19 | 2.72 | 5,581,730 | -0.7801 | -25.33% |
| 3 Months | 1.65 | 3.57 | 1.60 | 2.69 | 7,156,523 | 0.6499 | 39.39% |
| 6 Months | 1.13 | 3.57 | 0.9634 | 2.29 | 4,932,730 | 1.17 | 103.53% |
| 1 Year | 0.5602 | 3.57 | 0.51 | 1.96 | 3,266,881 | 1.74 | 310.55% |
| 3 Years | 1.41 | 3.57 | 0.37 | 1.81 | 2,372,491 | 0.8899 | 63.11% |
| 5 Years | 0.5699 | 5.97 | 0.37 | 1.87 | 1,974,391 | 1.73 | 303.56% |
Sesen Bio Description
| Sesen Bio Inc is a late-stage clinical company engaged in next-generation antibody-drug conjugate therapies for the treatment of cancer-based on the company's Targeted Protein Therapeutics platform. The company's lead program, Vicinium, also known as VB4-845, is currently in a Phase 3 registration trial, the VISTA Trial, for the treatment of high-grade non-muscle invasive bladder cancer. |
